CSIC
AGN

Clifford Swan Investment Counsel’s Allergan Inc AGN Stock Holding History

Clifford Swan Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,420
Closed -$1.15M – 266
2014
Q4 		$1.15M Sell
5,420
-9,435
-64% -$1.88M 0.08% 130
2014
Q3 		$2.65M Sell
14,855
-8,500
-36% -$1.41M 0.18% 100
2014
Q2 		$3.95M Sell
23,355
-1,297
-5% -$202K 0.27% 82
2014
Q1 		$3.06M Sell
24,652
-900
-4% -$110K 0.21% 91
2013
Q4 		$2.84M Buy
25,552
+3,437
+16% +$328K 0.21% 95
2013
Q3 		$2M Buy
+22,115
New +$1.99M 0.16% 99

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Clifford Swan Investment Counsel's AGN Position: Q1 2015 in Review

Clifford Swan Investment Counsel sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 5,420 shares — an estimated $1.15M sold.

Clifford Swan Investment Counsel first reported a position in AGN in Q3 2013 and held it in 6 quarters. The position peaked at $3.95M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Clifford Swan Investment Counsel reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Clifford Swan Investment Counsel sold 5,420 Allergan Inc shares in Q1 2015, an estimated $1.15M.
  • Clifford Swan Investment Counsel first reported a position in Allergan Inc in Q3 2013 and held it in 6 quarters.
  • Clifford Swan Investment Counsel's Allergan Inc position peaked at $3.95M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Clifford Swan Investment Counsel's 13F filing for Q1 2015, filed 15 May 2015.